Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Guaiphenesin; PSEUDOEPHEDRINE HYDROCHLORIDE
Haleon Ireland Limited
R01BA; R01BA52
Guaiphenesin; PSEUDOEPHEDRINE HYDROCHLORIDE
100 mg/5ml/30 mg/5ml
Oral solution
Sympathomimetics; pseudoephedrine, combinations
Marketed
1985-07-29
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ROBITUSSIN PLUS ORAL SOLUTION guaifenesin 100mg/5ml pseudoephedrine hydrochloride 30mg/5ml READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. You must talk to a doctor if you do not feel better or if you feel worse 5 days. IN THIS LEAFLET: 1. What ROBITUSSIN PLUS is and what it is used for 2. What you need to know before you take ROBITUSSIN PLUS 3. How to take ROBITUSSIN PLUS 4. Possible side effects 5. How to store ROBITUSSIN PLUS 6. Contents of the pack and other information 1. WHAT ROBITUSSIN PLUS IS AND WHAT IT IS USED FOR ROBITUSSIN PLUS contains the active ingredients guaifenesin and pseudoephedrine hydrochloride. Guaifenesin belongs to a group of medicines called cough expectorants and works by changing an unproductive cough to a cough that is more productive and less frequent. Pseudoephedrine hydrochloride belongs to a group of medicines called nasal decongestants and helps clear nasal congestion (a blocked or stuffy nose). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ROBITUSSIN PLUS Do not use in combination with any other medication unless your pharmacist approves it. DO NOT TAKE THIS MEDICINE IF: • You are allergic (hypersensitive) to guaifenesin or pseudoephedrine hydrochloride or any of the other ingredients of Robitussin Plus. • You are taking a monoamine oxidase inhibitor (MAOI) or have done so in the last 14 days. • You are taking other medicines for the relief of colds and flu, congestion or blocked nose, stimulant drugs called amphetamines (sometimes used to treat attention deficit disorders), appetite su Đọc toàn bộ tài liệu
Health Products Regulatory Authority 15 February 2024 CRN00DJ04 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Robitussin Plus Oral Solution Guaifenesin 100 mg/5ml Pseudoephedrine HCl 30 mg/5ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml of liquid contains: Guaifenesin 100 mg Pseudoephedrine HCl 30 mg Excipients with known effect Each 5ml contains; Ethanol (96%) 114.9 mg Sodium 13.76 mg Amaranth (E123) 0.033 mg Liquid Maltitol (E965) 242 mg Sorbitol Solution 70% (E420) 1.454 g Propylene glycol (E1520) 7.59 mg Sodium benzoate (E211) 6.0 mg For a full list of excipients, see 6.1. 3 PHARMACEUTICAL FORM Oral Solution A clear, pale pink-coloured liquid with a cherry flavour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Fixed combination of sympathomimetic and expectorant for use as a nasal decongestant and expectorant. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology ADULTS (INCLUDINGELDERLY) AND CHILDRENOVER12YEARS: 10 ml x 3 daily (this dose is not to be exceeded) At least 4 hours should elapse between two doses. This medicine is not to be used with other nasal decongestants or expectorants. The treatment duration should not exceed 5 days without medical advice. The maximum daily dose is 30 ml in any 24 hours (pseudoephedrine hydrochloride 240 mg, guaifenesin 800 mg). _PAEDIATRIC POPULATION_ Health Products Regulatory Authority 15 February 2024 CRN00DJ04 Page 2 of 8 This medicine should not be used in children under 12 years. _ELDERLY_ Caution is advised in patients over the age of 60 years. Patients in this age group are at greater risk of adverse reactions due to decreased renal function (see Section 4.4). _RENAL IMPAIRMENT_ Do not use in patients with severe renal impairment (GFR <30 ml/min) (see Section 4.3 and 4.4). _HEPATIC IMPAIRMENT_ Pseudoephedrine should be used cautiously in patients with severe hepatic impairment. Method of administration Take orally. 4.3 CONTRAINDICATIONS This medicine should not be given to children below 12 years of age (see Section 4.2) Đọc toàn bộ tài liệu